The host innate immune response is triggered within hours of virus infection. As a whole, its function is to limit virus replication at local sites of infection and to orchestrate development of the adaptive immune response. Viruses are typically recognized by cellular pattern recognition receptors (PRRs), including toll-like receptors (TLRs) and the retinoic acid inducible gene (RIG)-like RNA helicases (RLHs). Ligation of these PRRs, often by viral nucleic acids, culminates in the activation of multiple transcription factors that cooperate in driving expression of cytokines and chemokines characteristic of the innate response. Nuclear factor-kappa B (NF-kappaB) and interferon (IFN) regulatory factors (IRFs) are particularly important transcription factors, responsible for induction of type I IFN (IFNalpha/beta), tumor necrosis factor alpha (TNFalpha) and other mediators of inflammation. IFNalpha/beta is central to the anti-viral response as it initiates its own transcriptional program resulting in expression of IFN-stimulated genes (ISGs) via the Janus kinase-signal transducer and activation of transcription (JAK-STAT) pathway. ISG expression influences many cellular processes including RNA processing, protein stability and cell viability that can directly affect virus replication. ISG expression in cells of the immune system such as dendritic cells (DCs) and macrophages is critical for antigen presentation and T- and B-cell activation, thus affecting the quality of the adaptive immune response and eventual virus clearance. To facilitate dissemination, pathogenic viruses have evolved mechanisms to suppress host innate immunity by antagonizing these signal transduction pathways. Hence, understanding the specific pathways by which viruses activate and evade innate immune responses is essential for understanding viral pathogenesis as well as for development of effective vaccines. To examine virus-host interactions that affect innate immunity, our laboratory utilizes flaviviruses as the primary model of infection. Flaviviruses have an essentially global distribution and represent a tremendous disease burden to humans, causing millions of infections annually. The success of flaviviruses as human pathogens is associated with the fact that they are arthropod-borne, transmitted by mosquitoes or ticks. Significant members of this group include dengue virus (DENV) and yellow fever virus (YFV) that cause hemorrhagic fevers, as well as Japanese encephalitis virus (JEV), West Nile virus (WNV) and tick-borne encephalitis virus (TBEV) that cause severe encephalitides. These viruses are listed as NIAID category A, B and C pathogens for research into their basic biology and host response. The flavivirus single-stranded RNA genome is translated as one open reading frame;the resulting polyprotein is cleaved into at least ten proteins that include three structural (capsid C, membrane M, derived from the precursor preM and envelope E), and seven nonstructural proteins (NS1, NS2A, NS2B, NS3, NS4A, NS4B and NS5). Virus replication proceeds in association with modified membranes derived from the endoplasmic reticulum of host cells. NS5 is the largest and most conserved of the flavivirus proteins containing approximately 900 amino acids. It encodes a methyltransferase (MTase) and RNA-dependent RNA polymerase (RdRP) and associates with NS3 (the viral protease) to form the functional unit of the viral replication complex. Despite the widespread and often severe infections caused by these pathogens, vaccines exist for only a few (YFV, JEV and TBEV) and no therapeutic exists to treat clinical infection caused by any flavivirus. Type I IFNs are essential to recovery from flavivirus infection and have been used clinically as potential therapeutics, albeit with limit success. This may be due to the observation that all flaviviruses examined to date antagonize IFN-dependent responses by suppressing JAK-STAT signal transduction. We identified NS5 as the major IFN antagonist encoded by flaviviruses, originally using Langat virus (LGTV;a member of the TBEV complex of flaviviruses) and most recently using WNV. Although other NS proteins contribute to suppression of JAK-STAT signaling, studies by our laboratory and others suggest that NS5 is the most potent of the IFN antagonist proteins encoded by all vector-borne flaviviruses examined thus far. Hence, determining the mechanism(s) by which NS5 impedes signaling is essential to understand flavivirus pathogenesis and may lead to new therapeutic targets. Furthermore, it is important to understand the mechanisms underlying the anti-viral effects of IFN by identifying the function of ISGs with anti-viral activity. Finally, it is essential to translate these findings to immunologically relevant cell types and animal models to understand the roles of induction and evasion of innate immunity in development of the adaptive immune response and in virus pathogenesis. Our progress this year it to further understand the effects of flavivirus infection on DC maturation. Maturation of DCs and their subsequent ability to initiate adaptive immune responses is coordinated by PRR ligation, transcription factor activation and type I IFN) production. Early activation of interferon regulatory factor-1 (IRF-1), a transcription factor, results in expression of broadly acting antiviral effector genes including interleukin-12 (IL-12), a cytokine that plays an essential role in bridging innate and adaptive immune responses. To understand the impact of tick-borne flaviviruses on DC responses, we examined the maturation profile and cytokine response of murine bone marrow-derived DCs infected with Langat virus (LGTV;a member of the TBEV serogroup). In response to PRR stimulation, LGTV infected DCs showed enhanced production of TNF-alpha and IL-6, but suppressed IL-12 compared to uninfected cells in the same culture or mock-infected controls. The differential modulation of IL-12 was due to reduced expression of IL-12p40 mRNA, but not that of IL-12p35. Kinetic analysis revealed that early IL-12p40 mRNA expression required IRF-1 whereas sustained gene expression was dependent on signaling through the IFN receptor (IFNAR). Examination of IRF-1 status revealed that LGTV or TBEV infection resulted in accelerated IRF-1 degradation. Moreover, DCs enriched from LGTV infected Ifnar-/- mice showed impaired IRF-1 nuclear localization. Irf-1-/- mice were highly susceptible to LGTV infection suggesting that IRF-1 antagonism contributes to virus pathogenesis. Thus, IRF-1 degradation is a novel mechanism that synergizes with the noted ability of flaviviruses to suppress IFNAR-dependent signaling, resulting in the orchestrated evasion of host innate immunity.

Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Zip Code
de Wit, Emmie; Kramer, Shelby; Prescott, Joseph et al. (2016) Clinical Chemistry of Patients With Ebola in Monrovia, Liberia. J Infect Dis :
Grant, Alesha; Ponia, Sanket S; Tripathi, Shashank et al. (2016) Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling. Cell Host Microbe 19:882-90
de Wit, Emmie; Rosenke, Kyle; Fischer, Robert J et al. (2016) Ebola Laboratory Response at the Eternal Love Winning Africa Campus, Monrovia, Liberia, 2014-2015. J Infect Dis :
Best, Sonja M (2015) Is the third interferon a charm? Sci Transl Med 7:284fs16
Dunham, Eric C; Banadyga, Logan; Groseth, Allison et al. (2015) Assessing the contribution of interferon antagonism to the virulence of West African Ebola viruses. Nat Commun 6:8000
Marzi, Andrea; Robertson, Shelly J; Haddock, Elaine et al. (2015) EBOLA VACCINE. VSV-EBOV rapidly protects macaques against infection with the 2014/15 Ebola virus outbreak strain. Science 349:739-42
Lubick, Kirk J; Robertson, Shelly J; McNally, Kristin L et al. (2015) Flavivirus Antagonism of Type I Interferon Signaling Reveals Prolidase as a Regulator of IFNAR1 Surface Expression. Cell Host Microbe 18:61-74
Huang, Qinfeng; Luo, Yong; Cheng, Fang et al. (2014) Molecular characterization of the small nonstructural proteins of parvovirus Aleutian mink disease virus (AMDV) during infection. Virology 452-453:23-31
Schnettler, Esther; Tykalová, Hana; Watson, Mick et al. (2014) Induction and suppression of tick cell antiviral RNAi responses by tick-borne flaviviruses. Nucleic Acids Res 42:9436-46
Robertson, Shelly J; Lubick, Kirk J; Freedman, Brett A et al. (2014) Tick-borne flaviviruses antagonize both IRF-1 and type I IFN signaling to inhibit dendritic cell function. J Immunol 192:2744-55

Showing the most recent 10 out of 20 publications